ATE438647T1 - N-ä3- ä3-(dimethylamino)-1-oxo-2-propenylüphenylü-n-e hyl-acetamide hydrochlorid - Google Patents
N-ä3- ä3-(dimethylamino)-1-oxo-2-propenylüphenylü-n-e hyl-acetamide hydrochloridInfo
- Publication number
- ATE438647T1 ATE438647T1 AT08008434T AT08008434T ATE438647T1 AT E438647 T1 ATE438647 T1 AT E438647T1 AT 08008434 T AT08008434 T AT 08008434T AT 08008434 T AT08008434 T AT 08008434T AT E438647 T1 ATE438647 T1 AT E438647T1
- Authority
- AT
- Austria
- Prior art keywords
- dimethylamino
- oxo
- propenylüphenylü
- hyl
- acetamide hydrochloride
- Prior art date
Links
- FZSDJRKAWHMQFF-UHFFFAOYSA-N n-[3-[3-(dimethylamino)prop-2-enoyl]phenyl]-n-ethylacetamide;hydrochloride Chemical compound Cl.CCN(C(C)=O)C1=CC=CC(C(=O)C=CN(C)C)=C1 FZSDJRKAWHMQFF-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/34—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups
- C07C233/42—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring
- C07C233/43—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of a saturated carbon skeleton
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Anesthesiology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU0400325A HUP0400325A3 (en) | 2004-02-02 | 2004-02-02 | Pure n-[3-(-cyanopyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-n-ethyl-acetamide, process for its preparation and intermediates |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE438647T1 true ATE438647T1 (de) | 2009-08-15 |
Family
ID=89981959
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT05708499T ATE420882T1 (de) | 2004-02-02 | 2005-01-31 | Verfahren zur synthese von n-ä3-(3- cyanopyrazoloä1,5aüpyrimidin-7-yl)-phenylü-n- ethylacetamid |
| AT08008434T ATE438647T1 (de) | 2004-02-02 | 2005-01-31 | N-ä3- ä3-(dimethylamino)-1-oxo-2-propenylüphenylü-n-e hyl-acetamide hydrochlorid |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT05708499T ATE420882T1 (de) | 2004-02-02 | 2005-01-31 | Verfahren zur synthese von n-ä3-(3- cyanopyrazoloä1,5aüpyrimidin-7-yl)-phenylü-n- ethylacetamid |
Country Status (9)
| Country | Link |
|---|---|
| EP (2) | EP1950213B1 (de) |
| JP (1) | JP2007519700A (de) |
| AT (2) | ATE420882T1 (de) |
| DE (2) | DE602005012365D1 (de) |
| EA (1) | EA010830B1 (de) |
| HU (1) | HUP0400325A3 (de) |
| NO (1) | NO20063917L (de) |
| RS (1) | RS20060427A (de) |
| WO (1) | WO2005073235A2 (de) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005099712A2 (en) * | 2004-04-19 | 2005-10-27 | Sanmar Speciality Chemicals Limited | Process for preparation of n-[3-(3-cyanopyrazolo [1,5-a]pyrimidin-7-yl)phenyl]-n-ethylacetamide |
| WO2006070244A2 (en) * | 2004-11-22 | 2006-07-06 | Bakulesh Mafatlal Khamar | A process for the preparation of zaleplon |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4626538A (en) | 1983-06-23 | 1986-12-02 | American Cyanamid Company | [7-(3-disubstituted amino)phenyl]pyrazolo[1,5-a]pyrimidines |
| US5714607A (en) | 1995-12-01 | 1998-02-03 | American Cyanamid Company | Process improvement in the synthesis of N- 3-(3-cyano-pyrazolo 1,5-a!pyrimidin-7-yl)phenyl!-N-ethylacetamide |
| TR200402588T3 (tr) * | 2001-06-12 | 2004-11-22 | Biogal Gyogyszergyar Rt | N-[3-(3-siyanopirazolo[1,5-A]pirimidin-7-il)fenil]-N- etilasetamidin(zaleplon) üretim işlemi |
| CA2453751A1 (en) * | 2001-08-01 | 2003-02-13 | Biogal Gyogyszergyar Rt. | Purification and crystalline forms of zapelon |
| PL207322B1 (pl) * | 2002-05-14 | 2010-11-30 | Adamed Społka Z Ograniczoną Odpowiedzialnością | Sposób wytwarzania zaleplonu |
-
2004
- 2004-02-02 HU HU0400325A patent/HUP0400325A3/hu unknown
-
2005
- 2005-01-31 DE DE602005012365T patent/DE602005012365D1/de not_active Expired - Fee Related
- 2005-01-31 AT AT05708499T patent/ATE420882T1/de not_active IP Right Cessation
- 2005-01-31 AT AT08008434T patent/ATE438647T1/de not_active IP Right Cessation
- 2005-01-31 EA EA200601417A patent/EA010830B1/ru not_active IP Right Cessation
- 2005-01-31 EP EP08008434A patent/EP1950213B1/de not_active Expired - Lifetime
- 2005-01-31 JP JP2006550312A patent/JP2007519700A/ja active Pending
- 2005-01-31 RS RSP-2006/0427A patent/RS20060427A/sr unknown
- 2005-01-31 DE DE602005015902T patent/DE602005015902D1/de not_active Expired - Fee Related
- 2005-01-31 EP EP05708499A patent/EP1711501B1/de not_active Expired - Lifetime
- 2005-01-31 WO PCT/HU2005/000008 patent/WO2005073235A2/en not_active Ceased
-
2006
- 2006-09-01 NO NO20063917A patent/NO20063917L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EP1950213A3 (de) | 2008-08-13 |
| DE602005015902D1 (de) | 2009-09-17 |
| RS20060427A (sr) | 2008-08-07 |
| EP1950213A2 (de) | 2008-07-30 |
| EA200601417A1 (ru) | 2006-12-29 |
| JP2007519700A (ja) | 2007-07-19 |
| NO20063917L (no) | 2006-11-01 |
| HUP0400325A3 (en) | 2005-11-28 |
| HU0400325D0 (en) | 2004-04-28 |
| EP1711501A2 (de) | 2006-10-18 |
| WO2005073235A3 (en) | 2005-10-06 |
| HUP0400325A2 (hu) | 2005-09-28 |
| ATE420882T1 (de) | 2009-01-15 |
| EA010830B1 (ru) | 2008-12-30 |
| EP1950213B1 (de) | 2009-08-05 |
| DE602005012365D1 (de) | 2009-03-05 |
| WO2005073235A2 (en) | 2005-08-11 |
| EP1711501B1 (de) | 2009-01-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1109599T1 (el) | Κρυσταλλικες μορφες υδροχλωρικης (r)-8-χλωρο-1-μεθυλο-2,3,4,5-τετραϋδρο-1η-3-βενζαζεπινης | |
| HUS2100028I1 (hu) | ERBB I. típusú receptor tirozinkináz-gátló N4-fenil-kinazolin-4-amin származékok és rokon vegyületeik a hiperproliferatív betegségek kezelésére | |
| DE602004007905D1 (de) | Kristalline Formen von (-)-(1R,2R)-3-(3-Dimethylamino-1-ethyl-2-methylpropyl)-phenol hydrochlorid | |
| NZ592533A (en) | METHOD FOR THE PREPARATION OF N-(5-CHLORO-2-PYRIDINYL)-2-[[4-[(DIMETHYLAMINO) IMINOMETHYL] BENZOYL] AMINO]-5-METHOXY-BENZAMIDE, A FACTOR Xa INHIBITOR | |
| MY141255A (en) | Phosphodiesterase 4 inhibitors, including n-substituted diarylamine analogs | |
| NO20071642L (no) | N-Benzensulfonylsubstituerte anilino-pyrimidinanaloger | |
| DK1613304T3 (da) | DPP-IV-inhibitorer | |
| HUE051230T2 (hu) | Linezolid kristályos formája | |
| IL183663A0 (en) | Process for the preparation of a 2-ethylaminopyridine derivative | |
| BR0213931A (pt) | Forma polimórfica de rimonabant, processo para sua preparação e composições farmacêuticas contendo-as | |
| ATE512961T1 (de) | Amorphes nebivolol hydrochlorid und seine herstellung | |
| ATE452882T1 (de) | Herstellung von quetiapin | |
| AR041297A1 (es) | Derivados de 4-pirrolidino- fenil- bencil eter | |
| EA200801608A1 (ru) | Производные бензимидазолонкарбоновой кислоты | |
| UY27842A1 (es) | Fluorobenzamidas | |
| MX2007004637A (es) | Sintesis asimetrica de derivados de dihidrobenzofurano. | |
| IN2012DN00758A (de) | ||
| IL155041A0 (en) | Process for the preparation of n-(substituted phenyl)-3-alkyl-, aryl-and heteroarylsulfonyl-2-hydroxy-2-alkyl-and haloalkylpropanamide compounds | |
| NO20070550L (no) | Fremgangsmate for fremstilling av pyrrolotriazinforbindelser | |
| ATE438647T1 (de) | N-ä3- ä3-(dimethylamino)-1-oxo-2-propenylüphenylü-n-e hyl-acetamide hydrochlorid | |
| WO2008072079A3 (en) | Processes for the preparation of 3-(4-(2,4-difluorobenzyloxy)-3-bromo-6-methyl-2-oxopyridin-1(2h)-yl)-n,4-dimethylbenzamide | |
| DE602007012725D1 (de) | Verfahren zur Herstellung von N-(Diphenylmethyl)piperazinen | |
| NO20062152L (no) | Fremstilling av 3-azabicyklo [3.1.0.]heksanderivater | |
| NO20050885L (no) | Ny fremgangsmate for syntesen av 1,3-dihydro-2H-3-benzazepin-2-onforbindelser, og anvendelse i syntesen av ivabradin og addisjonssalter derav med en farmasoytisk akseptabel syre | |
| ATE340161T1 (de) | Herstellung von quinapril hydrochlorid |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |